...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Phase 1b/2 trial expected to initiate 1Q 2019

 In early February TD Waterhouse transferred from my non-registered account to my TFSA in less than five minutes on the phone.  USD value of $0.632 converted to CDN at the official exchange rate on the day I did the transfer. This could not have been easier to do. TD Waterhouse had all of the valuation information on hand and I did not have to provide them with anything.  Good luck. 

Share
New Message
Please login to post a reply